Vera Therapeutics VERA
NASDAQ VERA
$30.02 -0.01 (-0.03%)
As of: Nov 11, 2026 · 3:11 PM EST

Vera Therapeutics (VERA) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Vera Therapeutics' Return on Capital Employed [ROCE] came in at -78.59% for Q2 2026, down 36.50 percentage points from -42.09% a year earlier and down 18.03 percentage points from the prior quarter.

Analysis

Vera Therapeutics (VERA) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Vera Therapeutics' Return on Capital Employed [ROCE] was -49.16%, down 6.32 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a four-year change of +6.82 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -42.84% in FY2024 (+34.92 pp), -77.76% in FY2023 (+33.11 pp), -110.87% in FY2022 (-54.90 pp) and -55.97% in FY2021.
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q4 2022.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for five consecutive quarters, with an average year-over-year change of -5.93 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2022 (a gain of 65.47 percentage points), and the weakest in Q4 2022 (a drop of 42.79 percentage points).
  • Business Quant data shows VERA's Return on Capital Employed [ROCE] at -60.56% (Q1 2026), -55.09% (Q4 2025) and -53.38% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Vera Therapeutics 2.17 Bn -23.42 Mn 6.98 Mn -96.38%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -96.38%
Jun 30, 2026 -78.59%
Mar 31, 2026 -60.56%
Dec 31, 2025 -55.09%
Sep 30, 2025 -53.38%
Jun 30, 2025 -42.09%
Mar 31, 2025 -31.63%
Dec 31, 2024 -34.34%
Sep 30, 2024 -40.76%
Jun 30, 2024 -30.07%
Mar 31, 2024 -36.01%
Dec 31, 2023 -66.55%
Sep 30, 2023 -67.53%
Jun 30, 2023 -63.83%
Mar 31, 2023 -71.53%
Dec 31, 2022 -85.92%
Sep 30, 2022 -59.53%
Jun 30, 2022 -40.05%
Mar 31, 2022 -44.74%
Dec 31, 2021 -43.13%
API Access

Vera Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VERA&period=max&api_key=YOUR_API_KEY